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Summary
The adverse drug reaction (ADR) reporting rate within
the medical profession is exceptionally low, and
doctors' approaches and attitudes to ADRs were
explored through personal structured interviews. The
total sample comprised 104 doctors in private
practice, divided into three groups: 59 general practi-
tioners, 26 medical specialists and 19 surgical
specialists. Certain differences emerged between the
groups. The surgical group observed far fewer ADRs
than the other groups and not a single member had
ever reported an ADR. A significantly larger number
of medical specialists considered it necessary to
report an ADR t<;> an outside agency, while general
practitioners tended to believe that only newly
released medicines required ADR reporting. However,
few doctors of any specialtyfegarded ADR reporting
as part of the action they would take in their handling
of ADRs in practice. The commonest explanation
advanced for the marked underreporting of ADRs
was that unusual or serious reactions were very
infrequent and the common or trivial ones did not
warrant reporting. Apathy and indifference were rated
as the next most pertinent influence in non-com-
pliance, while such factors as fear of personal con-
sequences (e.g. criticism, medicolegal action) and
uncertainty about what to report were deemed to be
relatively unimportant
S AIr Med J 1987; 72: 1.31-1.34.
Post-marketing surveillance is essential for assessing the safety
of medicines, and voluntary reporting by doctors is necessary
for detecting adverse drug reactions (ADRs), especially when
these are rare.
The Medicines Safety Centre (MSC) is an independent and -
neutral body attached to the Department of Pharmacology of
the University of Cape Town and funded jointly by the
University of Cape Town and Ciba-Geigy (Pty) Ltd. One of
its principal functions is to monitor ADRs in the community.
Every quarter since January 1981 the MSC has circulated a
newsletter to all doctors, dentists and pharmacists in the
Western Cape enclosed with which is an ADR report form
and a business reply-paid envelope. Recipients are regularly
encouraged to notify the MSC of any ADR (however mild or
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common) by means of the form. Those who return the form
receive prompt feedback through a letter of thanks, coupled
with brief comments on the case from one of the MSC's
professional staff. Another ADR form with reply-paid enve-
lope accompanies the acknowledgement letter. Confidentiality
is guaranteed with regard to the names of doctors and patients.
The number of ADRs reported has remained fairly constant
but extremely low. During 1984 and 1985, approximately
14800 and 16000 forms respectively were distributed to doc-
tors, of which 144 and 149 respectively were returned - a
response rate of about 1%. The actual number of reporting
doctors was 106 for 1984 and 104 for 1985, of whom 38 and 45
respectively sent in more than one report. Therefore, between
2,5% and 3,0% of all doctors reported at least once during the
course of a year and only I%more than once.
The present survey set out to evaluate the attitudes of
doctors to ADR reporting in an attempt to identify the factors
responsible for the very low response rate. The study was
conducted on random samples of doctors in private practice by
means of a structured personal interview.
Subjects and methods
The study was restricted to doctors in private practice for two
reasons. Firstly, we wanted to interview doctors who were indivi-
dually responsible for the prescribing of medicines and who had
the sole responsibility to report ADRs. This was more easily
achieved in the private sector, because in hospitals doctors tend to
decide on medication as a team, so that the onus to notify ADRs
does not rest on a single person. Secondly, accurate lists of
hospital doctors are not generally available and this made random
sampling difficult. All private medical practitioners are listed in a
special section of the telephone directory which, in the case of
specialists registered with the South African Medical and Dental
Council, also designates their respective specialties. .
Groups selected
Using the current telephone directories for the Cape Town area
and its environs (Stellenbosch, Strand and Somerset West), we
alphabetically tabulated the names of and numbered every medical
practitioner in terms of the following groups: (I) general practi-
tioners (GPs); (il) medical specialists (MSs), including paediatri-
cians and psychiatrists; and (iil) surgical specialists (SSs), including
ophthalmologists and obstetricians and gynaecologists. We excluded
pathologists, radiologists and anaesthetists, who are not primarily
concerned with the regular prescribing of medicines for the treat-
ment and management of illness. .
Having drawn up master lists of doctors for each. group, we
used random number tables to generate samples from the three
groups so that each was represented numerically in the same
proportions as existed within the total population of doctors in
private practice.
Procedure
Each doctor was then approached telephonically and asked if
he/she would kindly give up 15 minutes to discuss ADRs. The
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5. Do you tell the pharmaceutical representative about
theADR?
doctor was subsequently visited and interviewed in his/her rooms
by one of us (M.W.). The various items in the interview ques-





















The following indicates that 104 doctors were -fInally interviewed
in the following groups:
SignifIcantly more of the GP group favoured informing the phar-
maceutical representative.
GP MS SS Total
No. of names drawn 73 28 20 121
Not available (e.g. holiday,
left practice) 12 2 0 14
Refused to co-operate 2 0 1 3
No. interviewed 59 26 19 104
6. Do you take action if your diagnosis of an ADR is
based on a strong suspicion rather than on certainty?
GP MS SS Towl
Yes 56 (95%) 24 (92%) 18 (95%) 98 (94%)
No 3 (5%) 2 (8%) 1 (5%) 6 (6%)
59 26 19 104
Not significant
Although over 90% said they would take action (e.g. withdrawing
the drug or reducing the dose), only 7 (7%) would contact the
MSC to report the reaction or ask advice.
7. Do you take action if the ADR is trivial?
Analysis of responses
The responses to the interview fell into two categories depending
on the questionnaire item: (1) specifIc answers (e.g. 'yes/no'),
which can easily be categorised and analysed; and (il) descriptive
answers, which cannot be categorised so easily; only the most
common responses are presented in this article.
The results are given separately for the GP, MS and SS groups,
and in the case of (1), the chi-square test was applied to detect




















2. Are ADRs a common or an unusual occurrence in your
practice?
Questionnaire items
1. What do you understand by the term 'adverse drug
reaction'? The three most common responses (in descending
order) given by the three groups were as follows:
GP MS SS
I. Unexpected reaction Unwanted reaction Unexpected reaction
2. Harmful reaction Unexpected reaction Harmful reaction
3. Unwanted reaction Harmful reaction Unwanted reaction
The consensus was that an ADR is an unwanted and/or unexpected



















Just over half the doctors answered in the affrrmative and said that
the action they would take would depend on the seriousness of the
patient's condition. They would usually withdraw the drug, reduce
the dose or change to an alternative.
8. Do you consider a well-established and common side-
effect to be an ADR?
GP MS SS Tocal
Yes 29 (49%) 13 (50%) 13 (68,5%) 55 (53%)
No 30 (51%) ..Q (50%) ~ (31,5%) ~ (47%)
59 ~ 19 104
In general, opinion on this question was almost equally divided.
There were no signifIcant differences between the three groups,
although proportionately more members of the surgical group
tended to regard a well-established side-effect as an ADR.
*One member of this group was unable to commit himself.
x' = 11,79; P < 0,01.
In general, ADRs were regarded as uncommon, but there was a
signifIcant difference between the groups in that none of the SSs
claimed that ADRs were common.
3. What happens in your practice when you encounter an
-ADR? Of the doctors in the total sample, 72 (69%) answered that
they would withdraw the drug and probably change to an alter-
native if that were possible. Only 13 (12,5%) - 6 GPs (10%), 6
MSs (23%) and I SS (5%) - spontaneously mentioned that, as
part of their usual practice, they would either report the ADR to











GP MS SS Total
New only 45 (76%) 5 (19%) 3 (16%) 53 (51%)
New and old 14 (24%) 21 (81%) 16 (84%) 51 (49%)
59 26 19 104
x' = 35,00; P< 0.D1_
9. Do you think it is important to report an ADR involving
an old medicine (i.e. one that has been available for years),
or is it only necessary to report on newly released
medicines?
Not significant
10. Do you take any action if the ADR is based solely on
the patient's subjective report (e.g. dizziness, depression)
and there are no objective signs?
GP MS
41 (69,5%) 18 (69%)
- 18 (30,5%) 8 (31%)
59 26
A large and signifIcantly higher proportion of the GP group
considered that it was important to report only on new medicines.
In the case of MSs and SSs, the great majority regarded it as
important to report on old as well as new medicines.
There were no signifIcant differences between the three groups,
although the surgical group was less likely to take action on the
basis of a subjective report. Of the doctors who answered in the
affIrmative, 21% would only take action under certain circum-




















x' = 10,32; P < 0,0 I.
4. Do you consider it necessary to advise
agency of an ADR and, if so, whom?
GP MS
31 (52,5%) 23 (88,5%)
28 (47,5%) 3 (11,5%)
59 26
SignifIcantly more of the MS group considered it necessary to
advise another agency of an ADR. Only half the GPs were of this
opinion.
The two most common agencies cited by those who answered in .
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H. Are you aware of the MSC and the quarterly news-
letter and ADR forms that it distributes?
GP ·MS SS Tow!
Yes 57 (97%) 24 (92%) 15 (79%) 96 (92%)
No 2 (3%) 2 (8%) 4 (21%) ~ (8%)
59 26 19 104
Very few doctors were not aware of the MSC, and there were no
significant differences between the three groups.
14. Do you think a telephone service whereby a doctor
could telephone in an ADR rather than filling in a form
would help?
GP MS SS Tow!
Yes 45 (79%) 18 (69%) 13 (68,5%) 76 (74,5%)
No/
uncertain 12(21%) 8 (31%) 6 (31,5%) 26 (25,5%)
Not significant
x' = 13,07; P < 0,01.
of the MSC or
The great majority of doctors regarded a telephone service as a
useful idea.
IS. Which of the following factors do you think are
important in explaining the low response rate of doctors to
ADR reporting? (These do not necessarily apply to you but
to doctors in general.) The following table lists the numbers
and percentages of those who responded in ehe affirmaeive. There












12. Have you ever used the services
·reported an ADR to the MSC?
GP MS
29 (47,5%) 10 (38,5%)




















6 (10,5%) 4 (15%)
49 (86%) 25 (96%) 18 (95%) 92 (90%)
2 (3,5%) 4 (15%) 1(5%) 7 (7%)
46 (81%) 23 (88,5%) 12 (63%) 81 (79,5%)
29(51%) 12 (46%) 10 (52,5%) 51 (50%)
8 (14%) 6 (23%) 7 (37%) 21 (20,5%)
15 (26%) 1(4%) 3 (16%) 19 (18,5%)
52(91%) 25 (96%) 14 (74%) 91 (89%)
45 (79%) 23 (88,5%) 16 (84%)
When evidence for





on more than one
drug, it is difficult
to know which is
responsible
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want to give a





busy, even if they
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The participation of doctors in spontaneous reporting schemes
is an efficient means of obtaining new ADR reports. l The
present survey was prompted by the remarkably low ADR
reporting rate in the Cape Town region despite persistent
efforts of the MSC to promote such reporting and to provide
feedback to those who co-operate. Only 2,5 - 3% of doctors
report at least once in the course of a year and 1% more than
once. A prospective study among GPs in the UK2 found that





















13. Do you have any com.ments or explanations as to why
so few doctors report ADRs to the MSC? Most of the
respondents gave more than one explanation. The factors listed
below were cited by at least 10% of the respondents in each group.
GP (57 subjeces*)
Very few ADRs are seen, and those that are are
minor, well-established and not worth reporting
Apathy
Too busy
Uncertain about what to report
ADR form is not readily available when needed
. MS (26)
Very few unusual ADRs are seen
Apathy
ADR form is not readily available when needed
Too busy
Ignorance of the value of the MSC and ADR
reporting
Burdened by too much paperwork
Would feel threatened or embarrassed
SS (19)
Very few ADRs are seen, and those that are are
minor, well-established and not worth reporting
Ignorance of the value of the MSC and ADR
reporting
Burdened by too much paperwork
Too busy
Apathy
ADR form is not readily available when needed
Unawareness of the existence of the MSC
....-rhc 2 doctors in the GP group who were not aware of the MSC and had never received the
ADR forms refused to comment on this and subsequent questions, since mey knew nothing
about the ADR reponing procedure.
Out of the total sample of 102, at least 10% of respondents gave
the following explanations for the poor reporting of ADRs:
1. Very few ADRs are seen, and when they are
observed they are minor, well-established and
not worth reporting
2. Apathy
3. Doctors are too busy to fmd time to complete
the ADR form
4. Ignorance of the value of the MSC and ADR
reporting
5. ADR form is not readily available when
needed
6. Doctors are already burdened by too much
paperwork 11 (11%)
It is of interest to note that only 9 doctors (9%), 8 of whom were
in the GP group, mentioned uncertainty about what to report.
Furthermore, only 5 doctors (5%) suggested that doctors did not
report ADRs because they feared personal criticism, embarrassment
or humiliation.
More than half the doctors had never used the MSC either to seek
advice or to report an ADR. A significantly greater percentage of
SSs had not used the MSC and none of the SSs had ever reported
an ADR. Of the 49 doctors who used the MSC, 26 (53%) had
reported an ADR.
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6,38 suspected ADRs, whereas the low number reported by
our doctor population over 1 year shows massive resistance to
ADR reporting. We therefore set out to explore doctors'
attitudes and approaches to ADRs by means of a structured
interview.
We confined our study to private practitioners for reasons
outlined above, but during 1984 and 1985, 21% and 23%
respectively of doctors reporting to the MSC were based in
hospitals. The hospital situation requires special study, since
many of the most serious ADRs are observed within a hospital
setting. Of the ADR returns from the private sector in 1984
and 1985, 86% and 84% respectively emanated from general
practitioners.
ADRs were regarded as common by about 40% of the GP
and MS groups, while 100% of the SS group deemed them
uncommon. Moreover, not a single SS interviewed had ever
submined an ADR report to the MSC, compared with 27%
and 38,5% of the GP and MS groups respectively. These
observations may reflect the fact that SSs use medicines less
(especially on a long-term basis) than the other groups.
About two-thirds of all doctors - and significantly more of
the MS group (88,5%) - considered it necessary to notify an
outside agency (usually the MSC) of an ADR, but only 12,5%
spontaneously indicated that it was part of their practice to
involve the MSC if they encountered an ADR. This did not
signify a lack of awareness of the MSC and its ADR monitoring
function, since 92% of all doctors interviewed were familiar
with the MSC and had received its mailings. On the other
hand, it was of interest that two-thirds of the GP group would
inform the pharmaceutical representative about an ADR, while
approximately two-thirds of the MS and SS groups would not
do so. Again, if doctors observed a reaction which they
strongly suspected was an ADR, over 90% of them would take
some action (e.g. withdrawing the drug or reducing the dose),
but only 7% would actually notify or seek advice from the
MSC.
Another area of difference between the doctors was that
over 80% of the MS and SS groups thought it important to
report ADRs on old as well as new medicines whereas 76% of
the GP group would limit themselves to newly released
medicines.
The critical issue is why doctors are so non-compliant about
ADR reporting, and it appears that the concept of an ADR is
central to this maner. The great majority of our respondents
considered an ADR to be an unexpected or harmful reaction;
in fact, on specific questioning, half of them excluded well-
established side-effects as ADRs.. Furthermore, by far the
commonest explanation volunteered for the under-reporting of
ADRs was that doctors observed very few unusual or severe
ADRs in practice and did not feel justified in reporting well-
known or minor reactions. Although unusual side-effects are
indeed rarely encountered, the ability to make a distinction
between common and uncommon effects presupposes a sound
grasp of the side-effects profile of the various medicines. This
certainly cannot be assumed, and the MSC has repeatedly
urged that all ADRs should be reported. Although our sample
of doctors considered serious ADRs to be worth reporting,
studies from the UK2 and Sweden3 indicate that doctors are
remiss about these too and fail even to report ADRs which are
life-threatening or result in hospitalisation.
The four other main reasons spontaneously given were (in
decreasing order) apathy, being too busy, not recognising the
value of ADR reporting and not having the ADR form at hand
when it is needed. All these factors represent a general attitude
of unconcern. It is interesting that, contrary to an oft-held
view, fear of personal consequences (e.g. medicolegal action or
criticism by peers) was not identified as an important influence
by our sample of respondents.
It has been suggested that the term drug even! might be
more acceptable than adverse drug reaceion and encourage
bener reporting because it does not directly incriminate the
medicine. We specilically asked this question, and very few
(10%) of our respondents agreed - in fact, one doctor replied
that to him a 'drug event' was a dinner hosted by a pharma-
ceutical company at a fashionable hotel!
Form-filling was regarded in a negative light by about 90%
of doctors and so we enquired whether an ADR 'telephone-in'
service might be more attractive than completing ADR forms.
This was endorsed by the great majority of doctors, and it is a
facility which might be developed further. However, as
increasing numbers of doctors have access to desk-top com-
puters, we are establishing a national computer-linked service
similar to the British 'Prestel'. This will provide immediately
accessible drug information to all practitioners who, in turn,
will be able to key in their ADR reports and get rapid,
individual feedback. It remains to be seen whether this will
facilitate ADR repprting.
This survey explored why 97% of doctors in the Cape Town
region never report an ADR in the course of a year despite
repeated pressure to do so by the MSC. The task of reporting
has fallen on a very small core of conscientious practitioners, a
trend which is similar but less extreme in the UK, where 80%
of ADR reports were submined by 7,4% of doctors within the
National Health Service.4 Apathy is undoubtedly a major
factor, especially against the backdrop of a busy practice.
Although there is a widespread lack of appreciation ·of the
importance of ADR reporting, we doubt whether further
anempts to inculcate positive anitudes will substantially
improve motivation. In France, Sweden and Norway ADR
reporting is mandatory, and yet despite the force of legal
decree the reporting rate remains 10w.3 The prognosis is poor
and it appears that, like all else which passes between doctors
and their patients, ADRs will continue to remain largely
outside the reach of an external agency.
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and Mr Dewald Gerber and Dr John Straughan for their construc-
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